argenx SE (ARGX)

Nasdaq · Healthcare · Biotechnology
$925.70-1.73%As of 2026-11-22 · USD
Last session low $925.15Last session high $948.67
52-week low $661.8552-week high $1,072.75
Market cap
$58.21B
Sector
Healthcare
P/E (TTM)
32.1x

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)53.7In the neutral range (30 to 70)
MACD (12, 26, 9)13.78Above its signal line (12.73); histogram 1.05
Bollinger %B (20, 2)49%Inside the bands (857.02 to 996.79)
SMA 20926.91Price is 0.1% below
SMA 50918.10Price is 0.8% above
SMA 200862.88Price is 7.3% above
ATR (20)2.93% of priceAverage true range per day
52-week position64%In the middle of the 661.85 to 1,072.75 range

About argenx SE

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Insider filings, 90 daysNo purchases and 13 sales (about $45.2M).
Latest fiscal yearEnded 2025-12-31: revenue of $4.15B and an operating margin of 25.4%.

More in Biotechnology